MFA
IQV
PBI

Sheila A. Stamps

Known title: DirectorCIK: 0001600782

Sheila A. Stamps's purchase track record

Sheila A. Stamps has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
9/7/2022PBI$55K+36.6%+50.2%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 25, 2026

No recent news for MFA. The only article listed is about DiviDog and does not mention MFA. Therefore, there are no recent events affecting MFA. The company’s technical and fundamental data remain unchanged. No new developments to report for the past week.

this person other insiders at MFA

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

IQVIA Expands Veeva Partnership and Raises Price Targets. IQVIA announced an expanded partnership with Veeva Systems to use clinical operations software across its development studies. This move coincides with reports of an improving demand environment and high win rates. Stifel recently raised its price target for the stock to $303, reflecting confidence in the company's backlog and operational updates.

this person other insiders at IQV

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 12, 2026

Pitney Bowes (PBI) posts strong cash flow, launches SendPro CX. The company disclosed robust cash flow, which analysts say improves its valuation appeal. It also introduced the SendPro CX series, expanding its product portfolio. These developments are noted alongside commentary that the stock offers a high dividend yield and may fit a steady‑growth profile. The news adds to recent coverage highlighting its attractive yield and potential upside.

this person other insiders at PBI

Transaction History

MFA▲ Buy$150K
IQV▲ Buy$0
PBI▲ Buy$55K
IQV▲ Buy$0
PBI▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.